Publicaciones en colaboración con investigadores/as de Shanghai Jiao Tong University (33)

2023

  1. Coronary angiography-derived index for assessing microcirculatory resistance in patients with non-obstructed vessels: The FLASH IMR study

    American Heart Journal, Vol. 263, pp. 56-63

  2. First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations

    Journal of Thoracic Oncology, Vol. 18, Núm. 2, pp. 204-222

  3. Optical coherence tomography and coronary revascularization: from indication to procedural optimization

    Trends in Cardiovascular Medicine, Vol. 33, Núm. 2, pp. 92-106

  4. Post-procedural and long-term functional outcomes of jailed side branches in stented coronary bifurcation lesions assessed with side branch Murray law–based quantitative flow ratio

    Frontiers in Cardiovascular Medicine, Vol. 10

  5. Practical Application of Coronary Physiologic Assessment: Asia-Pacific Expert Consensus Document: Part 1

    JACC: Asia, Vol. 3, Núm. 5, pp. 689-706

  6. Quantitative flow ratio versus fractional flow reserve for guiding percutaneous coronary intervention: design and rationale of the randomised FAVOR III Europe Japan trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 16, pp. e1358-e1364

  7. Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion

    American Journal of Clinical Dermatology, Vol. 24, Núm. 1, pp. 5-14

2022

  1. Angiography derived assessment of the coronary microcirculation: is it ready for prime time?

    Expert Review of Cardiovascular Therapy, Vol. 20, Núm. 7, pp. 549-566

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  3. Reproducibility of quantitative flow ratio: The QREP study

    EuroIntervention, Vol. 17, Núm. 15, pp. 1252-1259

2021

  1. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

    The Lancet, Vol. 398, Núm. 10317, pp. 2149-2159

  2. Corrigendum to ‘First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update’: [ESMO Open Volume 6, Issue 5, October 2021, 100273] (ESMO Open (2021) 6(5), (S2059702921002350), (10.1016/j.esmoop.2021.100273))

    ESMO Open

  3. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 2, pp. 198-211

  4. First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update

    ESMO Open, Vol. 6, Núm. 5

  5. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  6. New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases

    Frontiers in Aging Neuroscience, Vol. 13

  7. Resting distal to aortic pressure ratio and fractional flow reserve discordance affects the diagnostic performance of quantitative flow ratio: Results from an individual patient data meta-analysis

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 825-832

2020

  1. Quantitative flow ratio–guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial

    American Heart Journal, Vol. 223, pp. 72-80

  2. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

    Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091

  3. The Impact of Coronary Physiology on Contemporary Clinical Decision Making

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 14, pp. 1617-1638